Notify me when SILVERARC CAPITAL MANAGEMENT, LLC files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| IBIO | iBio, Inc. | Class A Common Stock | 10% | $1,740,993 | 2,181,422 | SilverArc Capital Management, LLC | 30 Sep 2025 | ||
| GUTS | FRACTYL HEALTH, INC. | Class A Common Stock | 8% | $16,854,000 | 10,600,000 | SilverArc Capital Management, LLC | 30 Sep 2025 | ||
| TELA | TELA Bio, Inc. | Class A Common Stock | 7.8% | $3,157,618 | 3,065,649 | SilverArc Capital Management, LLC | 31 Dec 2024 | ||
| ELUT | Elutia Inc. | Class A Common Stock | 5.9% | $3,992,287 | 1,782,271 | SilverArc Capital Management, LLC | 31 Dec 2024 | ||
| AVTX | Avalo Therapeutics, Inc. | Class A Common Stock | 5.5% | $9,162,919 | 720,922 | SilverArc Capital Management, LLC | 30 Sep 2025 | ||
| MTEM | Molecular Templates, Inc. | Common Stock | 0% | $0 | 0 | SilverArc Capital Management, LLC | 31 Dec 2024 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|